Related Experiment Videos
Radiation therapy for skin tumors
1Ellis Fischel Cancer Center, University of Missouri Hospitals and Clinics, Columbia.
Otolaryngologic Clinics of North America
|April 1, 1993
Summary
Radiation therapy offers gratifying results with few long-term side effects for various skin cancers. It is a recommended treatment for basal cell and squamous cell carcinomas, especially when surgery poses high risks.
Area of Science:
- Oncology
- Dermatology
- Radiation Oncology
Background:
- Skin malignancies encompass a range of cancers affecting the skin.
- Various treatment modalities exist, each with specific indications and outcomes.
- Radiation therapy is a well-established modality in cancer treatment.
Purpose of the Study:
- To evaluate the efficacy and role of radiation therapy in managing diverse skin malignancies.
- To identify specific skin cancer types where radiation therapy is a preferred or acceptable treatment option.
- To discuss the outcomes and potential sequelae associated with radiation therapy for skin cancers.
Main Methods:
- Review of existing literature on radiation therapy for skin cancers.
- Analysis of treatment outcomes and long-term sequelae.
- Comparison of radiation therapy with other treatment modalities like surgery.
Main Results:
- Radiation therapy provides gratifying results with minimal long-term sequelae for many skin malignancies.
- It is a preferred treatment for basal cell and squamous cell carcinomas when surgery is contraindicated or associated with high morbidity.
- Radiation therapy is a highly acceptable treatment for Kaposi's sarcoma, mycosis fungoides, and Merkel cell carcinoma, and a viable option for melanoma.
Conclusions:
- Radiation therapy is a valuable and effective treatment for a spectrum of skin cancers.
- Its role is particularly significant in cases where surgical intervention poses substantial risks or requires complex reconstruction.
- Further consideration of radiation therapy as a primary or alternative treatment is warranted for specific skin malignancies.